Patents by Inventor Thierry Ferreira

Thierry Ferreira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10520757
    Abstract: Disclosed is a method for verifying conformity with a predetermined criterion of use of a spectacle frame intended to receive two ophthalmic lenses, including: a) at least one geometrical, mechanical, and/or structural characteristic is determined and the frame category to which the frame belongs from a set of predetermined spectacle-frame categories is deduced therefrom; b) an outline of at least one of the ophthalmic lenses intended to be mounted in the spectacle frame or of a rim of this spectacle frame is determined; c) the value of each parameter from a list of parameters of the frame is evaluated, considering the frame category of step a); the value of at least some of the parameters being evaluated as a function of the outline determined in step b); d) the conformity of the spectacle frame to the predetermined criterion is deduced from the values of the parameters of the spectacle frame.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: December 31, 2019
    Assignee: Essilor International
    Inventors: Vincent Anatole, Thierry Allouis, Daniel Ferreira
  • Patent number: 10508269
    Abstract: The present invention relates to a new isolated polypeptide comprising an amino acid sequence having at least 75%, 80%, 85%, 90%, 95%, 99% or 100% identity to the full length amino acid sequence set forth in SEQ ID NO:1, and having a polyester degrading activity, and uses thereof.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: December 17, 2019
    Assignees: CARBIOS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE POITIERS
    Inventors: Luen-Luen Li, Thierry Ferreira, Willy Aucher, Steven Colas, Linette Lionelle Kadri
  • Patent number: 10231985
    Abstract: The present invention relates to the field of medicine. It more particularly relates to the use of compounds for preventing and/or treating dyslipidemia in a subject, said dyslipidemia typically being linked to the excess presence in the biological membranes, including in the biological membranes of non-adipocyte cells, of fatty acids, in particular of saturated long-chain fatty acids, and/or of sterols. The invention also relates to compositions, in particular pharmaceutical compositions and food supplements or complements, comprising such compounds, and to the uses thereof for preventing and/or treating dyslipidemia. The compounds and compositions according to the invention can in particular be advantageously used for preventing and/or treating a pathological condition selected from metabolic syndrome and/or a symptom or abnormality characteristic of metabolic syndrome, preferably for preventing or treating type 2 diabetes mellitus or hepatic steatosis.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: March 19, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE POITIERS, UNIVERSITY OF EXETER
    Inventors: Miroslava Spanova, Thierry Ferreira, Romain Clement, Shalinee Dhayal, Noël Morgan
  • Publication number: 20180051264
    Abstract: The present invention relates to a new isolated polypeptide comprising an amino acid sequence having at least 75%, 80%, 85%, 90%, 95%, 99% or 100% identity to the full length amino acid sequence set forth in SEQ ID NO:1, and having a polyester degrading activity, and uses thereof.
    Type: Application
    Filed: March 11, 2016
    Publication date: February 22, 2018
    Inventors: LUEN-LUEN LI, THIERRY FERREIRA, WILLY AUCHER, STEVEN COLAS, LINETTE LIONELLE KADRI
  • Publication number: 20170349723
    Abstract: The invention relates to a plastic compound comprising at least one polyolefin and a biological entity that degrades said polyolefin. The invention further relates to a process for preparing a plastic article wherein at least one polyolefin and one biological entity that degrades said polyolefin are mixed at a temperature at which the polyolefin is in a partially or totally molten state.
    Type: Application
    Filed: December 18, 2015
    Publication date: December 7, 2017
    Inventors: THIERRY FERREIRA, FREDERIQUE GUILLAMOT, STEVEN COLAS
  • Patent number: 9821000
    Abstract: The present invention relates to the field of medicine. It relates more particularly to the use of compounds to prevent and/or treat lipotoxicity in a subject, especially lipotoxicity by hypoxia. The invention relates more particularly to compositions, especially pharmaceuticals compositions and nutritional supplements or complements comprising such compounds as well as their use to prevent and/or treat lipotoxicity, especially lipotoxicity by hypoxia. The compounds and compositions of the invention can especially be advantageously used to prevent and/or treat a pathology from among pulmonary pathologies, especially cystic fibrosis or a chronic obstructive pulmonary disease.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: November 21, 2017
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Thierry Ferreira, Romain Ferru-Clement, Clarisse Vandebrouck
  • Publication number: 20160333147
    Abstract: The present invention relates to a process for preparing a polymer/biological entities alloy, comprising a step of mixing a polymer and biological entities that degrade it, during a heat treatment, said heat treatment being performed at a temperature T above room temperature and said biological entities being resistant to said temperature T, characterized in that said biological entities are chosen from enzymes that degrade said polymer and microorganisms that degrade said polymer.
    Type: Application
    Filed: July 26, 2016
    Publication date: November 17, 2016
    Inventors: Thierry Ferreira, Frederic Bataille, Cedric Dever, Jacques Barbier
  • Publication number: 20160287542
    Abstract: The present invention relates to the field of medicine. It relates more particularly to the use of compounds to prevent and/or treat lipotoxicity in a subject, especially lipotoxicity by hypoxia. The invention relates more particularly to compositions, especially pharmaceuticals compositions and nutritional supplements or complements comprising such compounds as well as their use to prevent and/or treat lipotoxicity, especially lipotoxicity by hypoxia. The compounds and compositions of the invention can especially be advantageously used to prevent and/or treat a pathology from among pulmonary pathologies, especially cystic fibrosis or a chronic obstructive pulmonary disease.
    Type: Application
    Filed: October 8, 2014
    Publication date: October 6, 2016
    Inventors: THIERRY FERREIRA, ROMAIN FERRU-CLEMENT, CLARISSE VANDEBROUCK
  • Publication number: 20160256429
    Abstract: The present invention relates to the field of medicine. It more particularly relates to the use of compounds for preventing and/or treating dyslipidemia in a subject, said dyslipidemia typically being linked to the excess presence in the biological membranes, including in the biological membranes of non-adipocyte cells, of fatty acids, in particular of saturated long-chain fatty acids, and/or of sterols. The invention also relates to compositions, in particular pharmaceutical compositions and food supplements or complements, comprising such compounds, and to the uses thereof for preventing and/or treating dyslipidemia. The compounds and compositions according to the invention can in particular be advantageously used for preventing and/or treating a pathological condition selected from metabolic syndrome and/or a symptom or abnormality characteristic of metabolic syndrome, preferably for preventing or treating type 2 diabetes mellitus or hepatic steatosis.
    Type: Application
    Filed: October 8, 2014
    Publication date: September 8, 2016
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE POITIERS, UNIVERSITY OF EXETER
    Inventors: MIROSLAVA SPANOVA, THIERRY FERREIRA, ROMAIN CLEMENT, SHALINEE DHAYAL, NOËL MORGAN
  • Patent number: 9428744
    Abstract: The present invention relates to a process for preparing a polymer/biological entities alloy, comprising a step of mixing a polymer and biological entities that degrade it, during a heat treatment, said heat treatment being performed at a temperature T above room temperature and said biological entities being resistant to said temperature T, characterized in that said biological entities are chosen from enzymes that degrade said polymer and microorganisms that degrade said polymer.
    Type: Grant
    Filed: June 18, 2014
    Date of Patent: August 30, 2016
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, UNIVERSITE DE POITIERS, VALAGRO CARBONE RENOUVELABLE POITOU—CHARENTES
    Inventors: Thierry Ferreira, Frederic Bataille, Cedric Dever, Jacques Barbier
  • Publication number: 20140303278
    Abstract: The present invention relates to a process for preparing a polymer/biological entities alloy, comprising a step of mixing a polymer and biological entities that degrade it, during a heat treatment, said heat treatment being performed at a temperature T above room temperature and said biological entities being resistant to said temperature T, characterized in that said biological entities are chosen from enzymes that degrade said polymer and microorganisms that degrade said polymer.
    Type: Application
    Filed: June 18, 2014
    Publication date: October 9, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS, UNIVERSITE DE POITIERS, VALAGRO CARBONE RENOUVELABLE POITOU-CHARENTES
    Inventors: Thierry Ferreira, Frederic Bataille, Cedric Dever, Jacques Barbier
  • Patent number: 8728776
    Abstract: The invention relates to strains of bacteria of the genus Ochrobactrum, that can degrade polylactic acid. The invention also relates to an enzyme that can degrade polylactic acid, characterized in that it is produced by said bacteria strains according to the invention. The invention also relates to the applications of said bacteria strains and said enzyme that can degrade polylactic acid.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: May 20, 2014
    Assignees: Centre National de la Recherche Scientifique—CNRS, Universite de Poitiers
    Inventors: Thierry Ferreira, Willy Aucher
  • Publication number: 20120184005
    Abstract: The invention relates to strains of bacteria of the genus Ochrobactrum, that can degrade polylactic acid. The invention also relates to an enzyme that can degrade polylactic acid, characterized in that it is produced by said bacteria strains according to the invention. The invention also relates to the applications of said bacteria strains and said enzyme that can degrade polylactic acid.
    Type: Application
    Filed: October 1, 2010
    Publication date: July 19, 2012
    Applicant: UNIVERSITE DE POITIERS
    Inventors: Thierry Ferreira, Willy Aucher
  • Patent number: 8078343
    Abstract: The general field of the invention relates to devices for controlling the two attitude reference units of the AHRS type for aircraft, each AHRS comprising at least a first set of magnetometer measurements and at least a second set of gyroscopic measurements, each AHRS having two modes of operation, the first mode, called slave mode supplying the flight system with the information coming from the first set, the second mode, called DG mode supplying the flight system with the information coming from the second set. The device according to the invention comprises a display and means for displaying within this display a control window for these two attitude reference units, said window comprising three regions, the first region dedicated to the first AHRS unit, the second region dedicated to the second AHRS unit, the third region dedicated to the simultaneous control of the two AHRS units.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: December 13, 2011
    Assignee: Thales
    Inventors: Thierry Ferreira, Sylvie Loizeau
  • Publication number: 20090138143
    Abstract: The general field of the invention relates to devices for controlling the two attitude reference units of the AHRS type for aircraft, each AHRS comprising at least a first set of magnetometer measurements and at least a second set of gyroscopic measurements, each AHRS having two modes of operation, the first mode, called slave mode supplying the flight system with the information coming from the first set, the second mode, called DG mode supplying the flight system with the information coming from the second set. The device according to the invention comprises a display and means for displaying within this display a control window for these two attitude reference units, said window comprising three regions, the first region dedicated to the first AHRS unit, the second region dedicated to the second AHRS unit, the third region dedicated to the simultaneous control of the two AHRS units.
    Type: Application
    Filed: November 21, 2008
    Publication date: May 28, 2009
    Applicant: Thales
    Inventors: Thierry FERREIRA, Sylvie Loizeau